Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET
International Journal of Molecular Sciences · 04.05.2024 · 25 (9) · 5018
DOI: 10.3390/ijms25095018 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.05.2024. Verfasst von Justyna M Adamska und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam Institute of Molecular and Life Sciences, Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1…. Hauptthemen laut MEDLINE: Receptors, CXCR4, Receptors, CXCR, Chemokine CXCL12, Protein Binding. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) Program, European Union’s Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) Program.
Abstract (Originalsprache)
NanoLuc-mediated bioluminescence resonance energy transfer (NanoBRET) has gained popularity for its ability to homogenously measure ligand binding to G protein-coupled receptors (GPCRs), including the subfamily of chemokine receptors. These receptors, such as ACKR3, CXCR4, CXCR3, play a crucial role in the regulation of the immune system, are associated with inflammatory diseases and cancer, and are seen as promising drug targets. The aim of this study was to optimize NanoBRET-based ligand binding to NLuc-ACKR3 and NLuc-CXCR4 using different fluorescently labeled chemokine CXCL12 analogs and their use in a multiplex NanoBRET binding assay of two chemokine receptors at the same time. The four fluorescent CXCL12 analogs (CXCL12-AZD488, -AZD546, -AZD594, -AZD647) showed high-affinity saturable binding to both NLuc-ACKR3 and NLuc-CXCR4, with relatively low levels of non-specific binding. Additionally, the binding of all AZDye-labeled CXCL12s to Nluc receptors was inhibited by pharmacologically relevant unlabeled chemokines and small molecules. The NanoBRET binding assay for CXCL10-AZD488 binding to Nluc-CXCR3 was also successfully established and successfully employed for the simultaneous measurement of the binding of unlabeled small molecules to NLuc-CXCR3 and NLuc-CXCR4. In conclusion, multiplexing the NanoBRET-based competition binding assay is a promising tool for testing unlabeled (small) molecules against multiple GPCRs simultaneously.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amsterdam Institute of Molecular and Life Sciences, Division of Medicinal Chemistry, Faculty of Science, Vrije Universiteit Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands.
ORCID-Profile: Justyna M Adamska, Henry F Vischer, Rob Leurs
Förderung
- European Union's Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) Program
- European Union’s Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) Program
Zitieren
APA
Adamska, J. M., Leftheriotis, S., Bosma, R., Vischer, H. F., & Leurs, R. (2024). Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET. International Journal of Molecular Sciences, 25(9), 5018. https://doi.org/10.3390/ijms25095018
Vancouver
Adamska JM, Leftheriotis S, Bosma R, Vischer HF, Leurs R. Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET. International Journal of Molecular Sciences. 2024;25(9):5018. doi:10.3390/ijms25095018
BibTeX
@article{Adamska2024,
author = {Adamska, Justyna M and Leftheriotis, Spyridon and Bosma, Reggie and Vischer, Henry F and Leurs, Rob},
title = {Multiplex Detection of Fluorescent Chemokine Binding to CXC Chemokine Receptors by NanoBRET},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {9},
pages = {5018},
doi = {10.3390/ijms25095018}
}
EUVIMED